Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Insiders Buying Plus Therapeutics And 2 Other Stocks Under $2

Author: Lisa Levin | November 09, 2023 09:51am

The Dow Jones closed lower by around 40 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Plus Therapeutics

  • The Trade: Plus Therapeutics, Inc. (NASDAQ:PSTV) Director Robert Lenk acquired a total of 7,395 shares an average price of $1.61. To acquire these shares, it cost around $11,933.
  • What’s Happening: Plus Therapeutics posted downbeat quarterly sales and announced a share repurchase program.
  • What Plus Therapeutics Does: Plus Therapeutics Inc is a clinical-stage pharmaceutical company. The company focused on the discovery, development, and delivery of complex and innovative treatments for patients battling cancer and rare diseases.

GeneDx Holdings

  • The Trade: GeneDx Holdings Corp. (NYSE:WGS) Director Richard Pfenniger Jr acquired a total of 10,000 shares at an average price of $1.49. To acquire these shares, it cost around $14,889.
  • What’s Happening: GeneDx Hldgs posted upbeat quarterly sales.
  • What GeneDx Holdings Does: GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery.

Check This Out: Fear & Greed Index Remains In 'Fear' Zone Ahead Of Fed Chair Powell's Speech

Socket Mobile

  • The Trade: Socket Mobile, Inc. (NASDAQ:SCKT) Director Charlie Bass acquired a total of 5,000 shares at an average price of $1.04. The insider spent around $5,218 to buy those shares.
  • What’s Happening: Socket Mobile posted a wider-than-expected third-quarter loss.
  • What Socket Mobile Does: Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education.

 

Don’t forget to check out our premarket coverage here

Posted In: PSTV SCKT WGS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist